Patents by Inventor H. Ian Robins

H. Ian Robins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cancer with thymidine in combination with temozolamide
    Patent number: 6642211
    Abstract: Methods for treating cancer are provided that involve administration of a combination of the chemotherapeutic drug, temozolamide, and thymidine.
    Type: Grant
    Filed: April 1, 2002
    Date of Patent: November 4, 2003
    Assignee: Wisconsin Alumni Research Foundation
    Inventor: H. Ian Robins
  • Treatment of cancer with thymidine in combination with temozolamide
    Publication number: 20020198183
    Abstract: Methods for treating cancer are provided that involve administration of a combination of the chemotherapeutic drug, temozolamide, and thymidine.
    Type: Application
    Filed: April 1, 2002
    Publication date: December 26, 2002
    Inventor: H. Ian Robins
  • Apparatus for inducing whole body hyperthermia and method for treatment utilizing said whole body hyperthermia inducing apparatus
    Patent number: 5713941
    Abstract: The present invention provides an improved whole body hyperthermia apparatus for raising the body temperature of a patient, said apparatus emitting radiant heat from a surface heated by a fluid. The present invention also provides an improved method for treating a cancer patient, said method comprising administering an anti-neoplastic agent to the cancer patient undergoing whole body hyperthermia under less stressful and more effective conditions with the improved whole body hyperthermia apparatus.
    Type: Grant
    Filed: April 27, 1993
    Date of Patent: February 3, 1998
    Assignee: Cancer Research Institute
    Inventors: H. Ian Robins, Justin D. Cohen
  • Method for localization and treatment of tumors using polylysine complexes
    Patent number: 5230883
    Abstract: Improved methods of selectively localizing, imaging and/or treating tumors, which have a net negative charge, employ novel compositions containing non-immunogenic complexes having a net positive charge in a sterile solution. The complexes contain polylysine, a linking agent bound to less than all of the lysyl groups of the polylysine, and an imaging agent or a chemotherapeutic agent which is also bound to the linking agent.
    Type: Grant
    Filed: January 27, 1992
    Date of Patent: July 27, 1993
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Steven Kornguth, Patrick Turski, H. Ian Robins, Robert J. Nickles